Tuesday, August 31, 2021 5:35:40 PM
In my experience charts reflect the expected business progress cycles and financials then inserts any surprises long the way. Those with a relatively low trading volume and investor base are easier to manipulate through the cycles and get targeted accordingly. Small pre revenue biotechs with promising tech but without big backers dilute for years creating a typical down trend which is the start of the W long term chart but with a low peak in the middle unlike the W using this font. This represents “no hope” converted to “maybe a chance” to “what’s taking so long” to “it’s coming”. Those with big long term backers often form an M looking chart if the product eventually is predicted to fail as “early hope and support” turns into “questioning” then “renewed hope” then “capitulation”. For the most part when financing is anticipated with no expected supporting news the price can drop towards book value or below and when completed the price is allowed to float back up with speculation about progress and any supporting news which includes sector outlook. The next interim cycle on the down trend side generally takes the lows lower and the highs lower but generally creates a 50% or better annual swing for traders to work with. The opposite often holds true for the big backer companies as they continue to enlist price support until the realization comes that failure is likely and someone decides to pull the plug.
The W formation was noted here and a close look at the trading action to create the “true double bottom” @ $.14 was really obvious last year. There are informed expectations being played out in the charts and that is what our chart guys like Sojourner55 are looking for. I told him it was his time to shine when the double bottom hit and if you have paid any attention to they bet of follows he has received since then you will note they have surged significantly; ). Best wishes.
Recent NWBO News
- Form PRE 14A - Other preliminary proxy statements • Edgar (US Regulatory) • 05/22/2024 08:13:36 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 05/10/2024 09:04:57 PM
- Form NT 10-K - Notification of inability to timely file Form 10-K 405, 10-K, 10-KSB 405, 10-KSB, 10-KT, or 10-KT405 • Edgar (US Regulatory) • 03/01/2024 10:04:38 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 12/02/2023 01:31:35 AM
- Form 8-K - Current report • Edgar (US Regulatory) • 11/16/2023 10:11:54 PM
- Epazz, Inc. (OTC Pink: EPAZ) ZenaDrone Demonstration to Defense Departments of UAE and Saudi Arabia • InvestorsHub NewsWire • 11/15/2023 12:19:31 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 11/09/2023 09:30:39 PM
- Epazz, Inc. (OTC Pink: EPAZ) US Navy Collaboration ZenaDrone 1000 • InvestorsHub NewsWire • 11/09/2023 01:00:34 PM
- Epazz, Inc. (OTC Pink: EPAZ) US Navy Collaboration ZenaDrone 1000 Extreme Weather Demo • InvestorsHub NewsWire • 11/07/2023 12:29:43 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 08/09/2023 08:36:14 PM
Avant Technologies Engages Wired4Tech to Evaluate the Performance of Next Generation AI Server Technology • AVAI • May 23, 2024 8:00 AM
Branded Legacy, Inc. Unveils Collaboration with Celebrity Tattoo Artist Kat Tat for New Tattoo Aftercare Product • BLEG • May 22, 2024 8:30 AM
"Defo's Morning Briefing" Set to Debut for "GreenliteTV" • GRNL • May 21, 2024 2:28 PM
North Bay Resources Announces 50/50 JV at Fran Gold Project, British Columbia; Initiates NI 43-101 Resources Estimate and Bulk Sample • NBRI • May 21, 2024 9:07 AM
Greenlite Ventures Inks Deal to Acquire No Limit Technology • GRNL • May 17, 2024 3:00 PM
Music Licensing, Inc. (OTC: SONG) Subsidiary Pro Music Rights Secures Final Judgment of $114,081.30 USD, Demonstrating Strength of Licensing Agreements • SONGD • May 17, 2024 11:00 AM